Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Skokowa, Julia  [Clear All Filters]
Journal Article
Dannenmann B, Nasri M, Welte K, Skokowa J. CRISPR/Cas9 Genome Editing of Human-Induced Pluripotent Stem Cells Followed by Granulocytic Differentiation. Methods Mol Biol. 2020;2115:471-483.
Nasri M, Ritter M, Mir P, Dannenmann B, Kaufmann MM, Arreba-Tutusaus P, Xu Y, Borbaran-Bravo N, Klimiankou M, Lengerke C, et al. CRISPR/Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia. Mol Ther. 2024.
Alvarez BHernandez, Skokowa J, Coles M, Mir P, Nasri M, Maksymenko K, Weidmann L, Rogers KW, Welte K, Lupas AN, et al. Design of novel granulopoietic proteins by topological rescaffolding. PLoS Biol. 2020;18(12):e3000919.
Zeidler A, Borbaran-Bravo N, Dannenmann B, Ritter M, Nasri M, Klimiankou M, Kandabarau S, Zahabi A, König J, Zeidler C, et al. Differential transcriptional control of hematopoiesis in congenital and cycling neutropenia patients harboring mutations. Haematologica. 2023.
Makaryan V, Zeidler C, Bolyard AAnna, Skokowa J, Rodger E, Kelley ML, Boxer LA, Bonilla MAnn, Newburger PE, Shimamura A, et al. The diversity of mutations and clinical outcomes for ELANE-associated neutropenia. Curr Opin Hematol. 2014.
Mir P, Ritter M, Welte K, Skokowa J, Klimiankou M. Gene Knockout in Hematopoietic Stem and Progenitor Cells Followed by Granulocytic Differentiation. Methods Mol Biol. 2020;2115:455-469.
Pogozhykh D, Karapinar DYilmaz, Klimiankou M, Gerschmann N, Ebetsberger-Dachs G, Palmblad J, Carlsson G, Masmas T, Kinsey S, Bartels M, et al. HAX1-related congenital neutropenia: Long-term observation in paediatric and adult patients enrolled in the European branch of the Severe Chronic Neutropenia International Registry (SCNIR). Br J Haematol. 2023.
Dannenmann B, Zahabi A, Mir P, Oswald B, Bernhard R, Klimiankou M, Morishima T, Zeidler C, Kanz L, Lachmann N, et al. Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34 cells preceding leukemic transformation. Exp Hematol. 2019.
Dannenmann B, Klimiankou M, Oswald B, Solovyeva A, Mardan J, Nasri M, Ritter M, Zahabi A, Arreba-Tutusaus P, Mir P, et al. iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia. Cell Stem Cell. 2021.
Zhang H, Goudeva L, Immenschuh S, Schambach A, Skokowa J, Eiz-Vesper B, Blasczyk R, Figueiredo C. MiR-155 is associated with the leukemogenic potential of the class IV granulocyte colony stimulating factor receptor in CD34+ progenitor cells. Mol Med. 2014.
Borbaran-Bravo N, Arreba-Tutusaus P, Ritter MU, Nasri M, Klimiankou M, Skokowa J. Regenerative medicine meets translational oncology: Modeling leukemic bone marrow niche. Cell Rep Med. 2022;3(8):100724.